RT-3DE联合血清Galectin-3及可溶性sST2对急性心肌梗死患者经皮冠状动脉介入术预后的评估价值OA
Evaluation value of RT-3DE combined with serum galectin-3 and soluble sST2 in prognosis of acute myocardial infarction patients undergoing percutaneous coronary intervention
目的 分析实时三维超声心动图(RT-3DE)联合血清半乳糖凝集素-3(Galectin-3)及可溶性生长刺激表达基因2蛋白(sST2)对急性心肌梗死(AMI)患者经皮冠状动脉介入术(PCI)预后的评估价值.方法 选取2022年1月—2024年1月在中山市小榄人民医院接受PCI治疗的102例AMI患者作为研究对象,所有患者术前行RT-3DE检查,记录左室舒张末期容积(LEDV)、左室收缩末期容积(LESV)、左室射血分数(LVEF)等左室功能指标,并检测血清Galectin-3、sST2水平.术后对患者进行为期1年的随访,将发生死亡、卒中、支架内血栓、再发心肌梗死、靶血管再次血运重建及大出血的患者设为预后不良组(42例),其他患者为预后良好组(60例).比较两组患者RT-3DE检查结果及血清Galectin-3、sST2水平.采用多因素一般Logistic回归模型分析患者预后不良的风险因素.绘制受试者工作特征(ROC)曲线评估RT-3DE联合血清Galectin-3、sST2对AMI患者PCI预后的评估价值.结果 术前预后不良组LEDV、LESV、Galectin-3及sST2水平均高于预后良好组(P<0.05),LVEF水平低于预后良好组(P<0.05).多因素一般Logistic回归分析结果显示:LEDV高[(OR)=1.076(95%CI:1.005,1.151)]、LESV 高[(OR)=1.290(95%CI:1.075,1.549)]、LVEF低[(OR)=0.749(95%CI:0.630,0.890)]、Galectin-3 高[(OR)=1.281(95%CI:1.096,1.498)]、sST2 高[(OR)=1.312(95%CI:1.146,1.502)]均是患者预后不良的危险因素(P<0.05).ROC曲线分析结果表明,RT-3DE联合血清Galectin-3及sST2对AMI患者PCI预后的预测价值较高,其敏感性为92.9%(95%CI:0.805,0.985),特异性为90.0%(95%CI:0.795,0.962),曲线下面积为0.969(95%CI:0.942,0.997).结论 RT-3DE联合血清Galectin-3、sST2可有效评估AMI患者PCI预后.
Objective To analyze the evaluation value of real-time three-dimensional echocardiography(RT-3DE)combined with serum galectin-3(Galectin-3)and soluble growth stimulation expressed gene 2 protein(sST2)in the prognosis of acute myocardial infarction(AMI)patients undergoing percutaneous coronary intervention(PCI).Methods A total of 102 AMI patients who underwent PCI in our hospital from January 2022 to January 2024 were selected as the research objects.All patients underwent preoperative RT-3DE examination to record left ventricular function indicators including left ventricular end-diastolic volume(LEDV),left ventricular end-systolic volume(LESV),and left ventricular ejection fraction(LVEF).Serum levels of Galectin-3 and sST2 were detected.Patients were followed up for 1 year after surgery.Those with death,stroke,in-stent thrombosis,recurrent myocardial infarction,re-revascularization,or bleeding were assigned to the poor prognosis group(n=42),and the others to the good prognosis group.RT-3DE results,Galectin-3 and sST2 levels were compared between the two groups(n=60).Logistic regression was used to analyze risk factors for poor prognosis,and ROC curve was adopted to evaluate the predictive value of RT-3DE combined with serum Galectin-3 and soluble sST2 for the prognosis of AMI patients after PCI.Results Specifically,the preoperative levels of LEDV,LESV,Galectin-3 and sST2 in the poor prognosis group were significantly higher than those in the good prognosis group(P<0.05),while the LVEF level was significantly lower(P<0.05).Results of logistic regression analysis indicated that elevated LEDV[(OR)=1.076(95%CI:1.005,1.151)],elevated LESV[(OR)=1.290(95%CI:1.075,1.549)],decreased LVEF[(OR)=0.749(95%CI:0.630,0.890)],elevated Galectin-3[(OR)=1.281(95%CI:1.096,1.498)]and elevated sST2[(OR)=1.312(95%CI:1.146,1.502)]were all independent risk factors for poor prognosis in patients(P<0.05).Receiver operating characteristic(ROC)curve analysis demonstrated that real-time three-dimensional echocardiography(RT-3DE)combined with serum Galectin-3 and sST2 had high predictive value for the prognosis of AMI patients after PCI,with a sensitivity of 92.9%(95%CI:0.805,0.985)and a specificity of 90.0%(95%CI:0.795,0.962)and the area under the curve of 0.969(95%CI:0.942,0.997).Conclusion RT-3DE combined with serum Galectin-3 and sST2 can effectively evaluate the prognosis of acute myocardial infarction patients undergoing PCI.
金国志;黄南清;张富;林忠超;谢许萍;谢学建;张瑞雄
汕头大学医学院小榄临床学院(中山市小榄人民医院) 超声科,广东 中山 528415汕头大学医学院小榄临床学院(中山市小榄人民医院) 心血管内科,广东 中山 528415汕头大学医学院小榄临床学院(中山市小榄人民医院) 超声科,广东 中山 528415汕头大学医学院小榄临床学院(中山市小榄人民医院) 超声科,广东 中山 528415汕头大学医学院小榄临床学院(中山市小榄人民医院) 超声科,广东 中山 528415汕头大学医学院小榄临床学院(中山市小榄人民医院) 超声科,广东 中山 528415汕头大学医学院小榄临床学院(中山市小榄人民医院) 检验科,广东 中山 528415
医药卫生
急性心肌梗死实时三维超声心动图半乳糖凝集素-3可溶性生长刺激表达基因2蛋白经皮冠状动脉介入术预后
acute myocardial infarctionreal-time three-dimensional echocardiographygalectin-3soluble growth stimulation expressed gene 2 proteinpercutaneous coronary interventionprognosis
《中国现代医学杂志》 2026 (9)
21-26,6
广东省自然科学基金(2022A1515010353)中山市社会公益科技研究项目(2023B1114)
评论